These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16678209)

  • 61. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Self-appraised, informant-reported, and objective memory and cognitive function in mild cognitive impairment.
    Chung JC; Man DW
    Dement Geriatr Cogn Disord; 2009; 27(2):187-93. PubMed ID: 19202338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [NeuroCogFX--a computer-based neuropsychological assessment battery for the follow-up examination of neurological patients].
    Fliessbach K; Hoppe C; Schlegel U; Elger CE; Helmstaedter C
    Fortschr Neurol Psychiatr; 2006 Nov; 74(11):643-50. PubMed ID: 17103364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages.
    Floris G; Borghero G; Chiò A; Secchi L; Cannas A; Sardu C; Calvo A; Moglia C; Marrosu MG
    Amyotroph Lateral Scler; 2012 Jan; 13(1):95-101. PubMed ID: 21895509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cognitive impairment and neurophysiological correlates in MS.
    Magnano I; Aiello I; Piras MR
    J Neurol Sci; 2006 Jun; 245(1-2):117-22. PubMed ID: 16697015
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures.
    Galvin JE; Roe CM; Morris JC
    Arch Neurol; 2007 May; 64(5):718-24. PubMed ID: 17502471
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuropsychological health in F-111 aircraft maintenance workers.
    Schofield PW; Gibson R; Tavener M; Attia JR; D'Este C; Guest M; Brown AM; Lee SJ; Horsley K; Harrex W; Ross J
    Neurotoxicology; 2006 Sep; 27(5):852-60. PubMed ID: 16584777
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuropsychological assessment: experimental and clinical research.
    Falautano M
    Neurol Sci; 2010 Nov; 31(Suppl 2):S223-6. PubMed ID: 20640469
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Neuropsychological assessment in multiple sclerosis].
    Barroso J; Nieto A; Olivares T; Wollmann T; Hernández MA
    Rev Neurol; 2000 May 16-31; 30(10):985-8. PubMed ID: 10919201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches.
    Butters N; Grant I; Haxby J; Judd LL; Martin A; McClelland J; Pequegnat W; Schacter D; Stover E
    J Clin Exp Neuropsychol; 1990 Dec; 12(6):963-78. PubMed ID: 2286659
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cognitive decline in Multiple Sclerosis patients.
    Koutsouraki E; Kalatha T; Grosi E; Koukoulidis T; Michmizos D
    Hell J Nucl Med; 2019; 22 Suppl():75-81. PubMed ID: 30877725
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropsychiatric manifestations of multiple sclerosis.
    Pinkston JB; Alekseeva N
    Neurol Res; 2006 Apr; 28(3):284-90. PubMed ID: 16687055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical characteristics of cortical multiple sclerosis.
    Zarei M
    J Neurol Sci; 2006 Jun; 245(1-2):53-8. PubMed ID: 16626743
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis.
    Feuillet L; Reuter F; Audoin B; Malikova I; Barrau K; Cherif AA; Pelletier J
    Mult Scler; 2007 Jan; 13(1):124-7. PubMed ID: 17294621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Understanding cognitive dysfunction in multiple sclerosis: integrating a first-person perspective with neuropsychological testing, neuroimaging, and cognitive neuroscience research.
    Courtney SM
    Cogn Behav Neurol; 2011 Dec; 24(4):227-30. PubMed ID: 22123588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Measures of cognitive and emotional changes in multiple sclerosis and underlying models of brain dysfunction.
    Gainotti G
    J Neurol Sci; 2006 Jun; 245(1-2):15-20. PubMed ID: 16626747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.